AbCellera Biologics logo
AbCellera Biologics ABCL
$ 9.63 -7.85%
report update icon

Quarterly report 2026-Q3
added 11-09-2026

AbCellera Biologics Operating Cycle | ABCL

Annual Operating Cycle AbCellera Biologics

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
173 202 - - - - - - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
202 173 188

Quarterly Operating Cycle AbCellera Biologics

2026-Q3 2026-Q2 2026-Q1 2025-Q4 2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
329 - - - 720 357 1.03 K - - - - - - - - - - - - - 23.2 43.2 5.46 - - 3.67 8.85 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
1.03 K 3.67 280

Operating Cycle of other stocks in the Biotechnology industry

Issuer Operating Cycle Price % 24h Market Cap Country
Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals
CYCC
185 - -5.98 % $ 34.1 M usaUSA
Diffusion Pharmaceuticals Diffusion Pharmaceuticals
DFFN
69.1 - 11.68 % $ 8.97 M usaUSA
Esperion Therapeutics Esperion Therapeutics
ESPR
99.7 - - $ 661 M usaUSA
Evofem Biosciences Evofem Biosciences
EVFM
309 - 7.55 % $ 38.1 M usaUSA
Eyenovia Eyenovia
EYEN
541 - 49.81 % $ 13.2 M usaUSA
FibroGen FibroGen
FGEN
2.28 K - - $ 889 M usaUSA
Amicus Therapeutics Amicus Therapeutics
FOLD
932 - - $ 4.47 B usaUSA
Happiness Biotech Group Limited Happiness Biotech Group Limited
HAPP
17 - 1.35 % $ 17.8 M chinaChina
Novavax Novavax
NVAX
85.6 $ 7.47 -3.24 % $ 1.21 B usaUSA
KalVista Pharmaceuticals KalVista Pharmaceuticals
KALV
213 - - $ 1.45 B britainBritain
KemPharm KemPharm
KMPH
98.4 - -0.34 % $ 200 M usaUSA
Kezar Life Sciences Kezar Life Sciences
KZR
38.3 - - $ 53.3 M usaUSA
NovaBay Pharmaceuticals NovaBay Pharmaceuticals
NBY
84.2 - - $ 11.3 M usaUSA
OncoCyte Corporation OncoCyte Corporation
OCX
213 - 17.22 % $ 355 K usaUSA
Verastem Verastem
VSTM
455 $ 6.33 -7.8 % $ 439 M usaUSA
Plus Therapeutics Plus Therapeutics
PSTV
71.1 - - $ 301 M usaUSA
Pluristem Therapeutics Pluristem Therapeutics
PSTI
9.6 K - -1.9 % $ 33.3 M israelIsrael
Qualigen Therapeutics Qualigen Therapeutics
QLGN
3.28 K - 5.59 % $ 1.16 M usaUSA
Qilian International Holding Group Limited Qilian International Holding Group Limited
QLI
173 - -6.08 % $ 184 M chinaChina
Sangamo Therapeutics Sangamo Therapeutics
SGMO
4.14 - - $ 50.4 M usaUSA
Salarius Pharmaceuticals Salarius Pharmaceuticals
SLRX
382 - - $ 2.64 M usaUSA
Sonnet BioTherapeutics Holdings Sonnet BioTherapeutics Holdings
SONN
8.21 - - $ 826 K usaUSA
Vaxart Vaxart
VXRT
187 - -25.06 % $ 46.3 M usaUSA
XOMA Corporation XOMA Corporation
XOMA
89.1 - - $ 485 M usaUSA